News - Desert King

Desert King® achieves EXCiPACT™ certification and strengthens its leadership in vaccine adjuvant production

Desert King®, a global leader in the vaccine adjuvant market based on Quillaja saponaria saponins, is proud to announce his EXCiPACT™ certification.

In vitro evaluation and molecular docking of QS-21 and quillaic acid from Quillaja saponaria Molina as gastric cancer agents

Abstract The cytotoxic mechanism of the saponin QS-21 and its aglycone quillaic acid (QA) was studied on human gastric cancer cells (SNU1 and KATO III). Both compounds sh...

Nano-scale quillaja extract can replicate fat for plant-based juiciness

Scientists are using Chilean quillaja extract to create nano-scale oleogels in plant-based proteins, mimicking the taste and texture of fat in meat and creating a ‘...

Benefits of Quillaja Saponaria for the Salmon Industry

“A safe, reliable, and natural solution for the salmon industry” After over five years of research collaboration between Desert King, leaders in the saponin m...

Los nuevos usos del Quillay – El Mercurio

Quillay, un sofisticado y prometedor negocio – Diario Financiero

Notice from Las Vegas IFT 2017

19/07/2017 Mr. Ray Kramer for Foodnavigator.com https://www.foodnavigator.com/Ingredients/Emulsifiers-stabilisers-hydrocolloids/Desert-King-banks-on-plantations-fo...

QS-21 enhances the early antibody response to oil adjuvant foot-and-mouth disease vaccine in cattle

Can Çokçalışkan, Tunçer Türkoğlu, Beyhan Sareyyüpoğlu, Ergün Uzunlu, Ayca Babak, Banu B. Özbilge, Veli Gülyaz Foot-and-mouth disease (FMD) is one of the most important an...